• Britannia Life Sciences will launch a normal course issuer bid on Aug. 10 to repurchase up to 8,112,717 common shares for cancellation.
• The buyback covers up to 5% of shares outstanding.
• The program runs for 12 months, ending Aug. 9, 2027, unless completed or terminated earlier.
• Purchases will be made on the Canadian Securities Exchange or alternative trading systems at prevailing market prices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Britannia Life Sciences Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608050830NEWSFILECNPR____20260805_307932_1) on August 05, 2026, and is solely responsible for the information contained therein.